About this item:

12 Views | 5 Downloads

Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”

Show all authors Show less authors


Journal Title:

Journal of Allergy and Clinical Immunology: In Practice


Volume 9, Number 2


, Pages 1039-1040

Type of Work:



Waqar and Agarwal1 make significant points regarding the rapid adoption of technology, specifically telemedicine, into fellowship programs. As all of the authors in the American Academy of Allergy, Asthma & Immunology telemedicine work group will attest to, many factors need to be taken into account before adopting a functional telemedicine platform in the clinic. Keeping up with current regulations to maintain compliance in light of the changes during the COVID-19 pandemic and beyond also requires considerable effort.2 What is uniquely addressed in this letter are the practical issues that allergists and immunologists face with telemedicine. Although spirometry is limited at this time, technologies are being created and implemented to accomplish home forced expiratory volume in 1 second measurement.3 Assessing and teaching the inhaler and emergency epinephrine device technique can be performed remotely and re-evaluated at follow-up visits via telemedicine. Telemedicine has also been valuable to evaluate and monitor our most at-risk patients, such as those with immunodeficiency, as they may be fearful of returning to the clinic for routine in-person evaluations. Time will reveal more data in our field as we are able to obtain cost-benefit analysis for allergy and immunology telemedicine encounters. By providing innovative, valuable, and cost-effective care while educating our fellows and continuing to rapidly adapt in times of need, we will persist in pushing open the door of modern medical technology in health care.
Export to EndNote